Moreover, patients who died of ccRCC showed homogenous loss of PRMT1 in 44.7%, while 41.8% had homogenous loss of ZEB1 (p = 0.044, p = 0.009, respectively) (Table 9). The gene discussed is PRMT1; the disease is nonpapillary renal cell carcinoma.